Kingsview Wealth Management LLC Acquires Shares of 264,888 SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Kingsview Wealth Management LLC purchased a new stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) in the fourth quarter, Holdings Channel.com reports. The fund purchased 264,888 shares of the company’s stock, valued at approximately $11,388,000. Kingsview Wealth Management LLC owned approximately 0.05% of SPDR S&P Pharmaceuticals ETF at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. JPMorgan Chase & Co. increased its position in shares of SPDR S&P Pharmaceuticals ETF by 36.2% during the third quarter. JPMorgan Chase & Co. now owns 4,443 shares of the company’s stock valued at $197,000 after acquiring an additional 1,182 shares during the last quarter. AlphaMark Advisors LLC raised its holdings in SPDR S&P Pharmaceuticals ETF by 5.9% during the 3rd quarter. AlphaMark Advisors LLC now owns 6,225 shares of the company’s stock valued at $276,000 after acquiring an additional 348 shares during the period. Stifel Financial Corp bought a new position in SPDR S&P Pharmaceuticals ETF in the 3rd quarter worth about $337,000. CX Institutional purchased a new position in SPDR S&P Pharmaceuticals ETF during the fourth quarter valued at approximately $438,000. Finally, First Citizens Bank & Trust Co. increased its holdings in shares of SPDR S&P Pharmaceuticals ETF by 9.5% in the third quarter. First Citizens Bank & Trust Co. now owns 72,053 shares of the company’s stock worth $3,196,000 after purchasing an additional 6,227 shares during the period.

SPDR S&P Pharmaceuticals ETF Trading Down 1.6 %

Shares of NYSEARCA XPH opened at $44.56 on Friday. SPDR S&P Pharmaceuticals ETF has a 12 month low of $38.88 and a 12 month high of $48.76. The firm has a market capitalization of $216.12 million, a price-to-earnings ratio of 14.39 and a beta of 0.87. The business has a 50-day moving average of $44.30 and a 200-day moving average of $44.49.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.